Author: admin

Johnson K. TM1, Loesch C.2, Esser J.1, Mann K.3, Eckstein A.1 1Department of Ophthalmology University of Essen, Germany, 2Institute for Medical Informatics, Biometry and Epidemiology University of Essen, Germany, 3Department of Medicine, Division of Endocrinology University of Essen, Germany Abstract Aim: To investigate differences in the clinical outcome of retrobulbar irradiation at 12, 16 and Read More

Beleslin B., Zarkovic M., Ciric J., Stojkovic M., Savic S., Trbojevic B. Institute of endocrinology, Belgrade, Serbia Abstract Background: Clucocorticoids are treatment od choice for moderate to severe Graves\ ophthalmopathy (GO).Objective: The aim of this study was to evaluate effects of gender, age, smoking, duration of eye disease, duration of hyperthyroidism, Cnical activity score (CAS) Read More

Covelli D.1, Campi I.1, Vannucchi G.1, Dazzi D.1, Currò N.2, Simonetta S.2, Beck-Peccoz P.1, Salvi M.1 1Endocrine Unit, Department of Medical Sciences, Fondazione Ospedale Policlinico IRCCS, University of Milan, 2Ophthalmology, Fondazione Ospedale Policlinico IRCCS, University of Milan Abstract Radioiodine therapy (131I) has been reported to trigger worsening of thyroid-associated orbitopathy (TAO), although pre-treatment with steroids Read More

Król A.1, Krawczyk A.1, Nowak M.3, Zarudzki L.2, Jurecka-Lubieniecka B.1, Hasse-Lazar K.1,  Paliczka-Cieślik E.1, Krajewska J.1, Michalik B.1, Jarząb B.1 1Department of Nuclear Medicine and Endocrine Oncology, MSC Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland, 2Department of Radiodiagnostics, MSC Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland, 3Department Read More

Vondrichova T.1,4, Parikh H.4, Brorsson H.2, Martensson T.2, Asman P.3, Groop L.1, 4, Hallengren B.1, 4, Lantz M.1, 4 1Department of Endocrinology, Malmö University Hospital, Malmö, Sweden, 2Department of Plastic Surgery, Malmö University Hospital, Malmö, Sweden, 3Department of Ophthalmology, Malmö University Hospital, Malmö, Sweden, 4Lund University, Department of Clinical Sciences Malmö, Diabetes and Endocrinology, Malmö, Read More

Sykorova V.1, Dvorakova S.1, Vaclavikova E.1, Ryska A.2, Kodetova D.3, Astl J.4, Duskova J.5, Smutny S.6, Vlcek P.7, Bendlova B.1 1Department of Molecular Endocrinology, Institute of Endocrinology, Prague, Czech Republic, 2Department of Pathology, Faculty of Medicine and University Hospital, Charles University, Hradec Kralove, Czech Republic, 3Institute of Pathology and Molecular Medicine, 2nd Medical Faculty, Charles Read More

Araujo P.PC1, Tincani A.J.2, Guilhen T.A.C.1, Morari C.E.1, Ward S. L.1 1Molecular Genetics of Cancer Laboratory, Department of Internal Medicine, Medical Science School – FCM, State University of Campinas – UNICAMP, State of Sao Paulo, Brazil, 2Head and Neck Division, Department of Surgery, State University of Campinas – UNICAMP, State of Sao Paulo, Brazil Abstract Read More

Luster M., Verburg F., Mäder U., Reiners Ch. University Clinic W?rzburg, W?rzburg, Germany Abstract Objectives: In differentiated thyroid carcinoma a larger tumour diameter is considered to indicate a poorer prognosis. This higher risk is most likely effectuated due to a higher rate of metastases and locally invasive growth in patients with larger carcinomas. The aim Read More

Perrino M.1, Vannucchi G.1, Colombo C.1, Vicentini L.2, Chiti A.3, Beck Peccoz P.1, Fugazzola L.1 1Department of Medical Sciences, Endocrine Unit Unviversity of Milan, IRCCS Fondazione Policlinico, Milan, Italy, 2Endocrine Surgery Unit, IRCCS Fondazione Policlinico, Milan, Italy, 3Nuclear Medicine Unit, IRCCS Istituto Clinico Humanitas, Milan, Italy Abstract The incidence of papillary thyroid cancer (PTC) is Read More

K?hne-Eversmann L.1, Weiss M.2, Pfluger T.2, Gaertner R.1 1Department of Endocrinology, Medizinische Klinik Innenstadt, University of Munich, 2Department of Nuclear Medicine, Innenstadt, University of Munich Abstract Objective: Patients with metastases of differentiated thyroid carcinoma that fail to trap iodine or are unresectable have a poor prognosis. Recent studies with PPAR-γ agonists have shown promising effects Read More